Skip to main content
Emerging therapies for MS.
[How phase III therapeutic trials in multiple sclerosis should be evaluated: advances and challenges].
[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis].